Société Loxo Oncology Inc
Actions
US5488621013
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 39 | 01/05/14 | |
President | - | - | |
Anthony Sireci
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Liz Beja
COO | Chief Operating Officer | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Compliance Officer | - | 01/04/18 | |
Human Resources Officer | - | - | |
Amy Rose
HRO | Human Resources Officer | - | 01/01/20 |
Philip Johnson
LAW | General Counsel | - | 01/11/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 30 614 536 | 29 481 314 ( 96,30 %) | 0 | 96,30 % |
Coordonnées société
Loxo Oncology, Inc.
281 Tresser Boulevard 9th floor
06901, Stamford
+203-653-3880
http://www.loxooncology.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+8,96 % | 105 Md | |
-1,43 % | 104 Md | |
+4,40 % | 22,94 Md | |
-12,15 % | 22,34 Md | |
-4,36 % | 19,25 Md | |
-39,98 % | 17,08 Md | |
-10,04 % | 16,96 Md | |
+6,79 % | 14,16 Md | |
+38,61 % | 12,63 Md |